MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Apoptosis"

  • 2024 International Congress

    Study of the functional role of circulating extracellular vesicles as mediators of inflammation in cellular models of Parkinson`s disease

    A. Yadav, E. Vacchi, S. Pinton, A. Kaelin-Lang, G. Melli (Bellinzona, Switzerland)

    Objective: To study mechanisms of cellular inflammation and neurodegeneration of EVs derived from patients with PD at different disease stages in cell-based disease models. Background:…
  • 2024 International Congress

    Spinocerebellar ataxia type 2 specific microRNAs may have an effect on neurodegeneration.

    R. Singh, V. Swarup, I. Ahmad, V. Anand, I. Singh, M. Faruq, A. Srivastava (NEW DELHI, India)

    Objective: 1.Identification of microRNA in whole blood PBMCs of SCA2 patients .2.Target prediction and pathway analysis of  spinocerebellar ataxia type 2 identified miRNAs.  3.Validation of…
  • 2024 International Congress

    the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms

    N. Palomba, E. Bianchini, D. Rinaldi, C. Strafella, V. Caputo, F. Garramone, P. Lombardo, F. Nicoletti, E. Giardina, T. Esposito, F. Pontieri, M. Alborghetti ()

    Objective: To study a possible association between polymorphisms of the genes coding for proteins involved in the UPR and the development of PD or PD…
  • 2023 International Congress

    Genetic and functional analysis of CCDC88C mutations in patients with Parkinson’s disease.

    S. Chen, J. Chen, X. Xie, W. Luo (Hangzhou, China)

    Objective: To investigate the association between rare deleterious CCDC88C variants and PD. Background: SCA40 is a rare form of spinocerebellar ataxia caused by heterozygous mutations…
  • MDS Virtual Congress 2021

    Silencing of hypoxia-inducible factor 1 alpha provokes a neuroprotective response in a SH-SY5Y model of Parkinson’s Disease.

    S. Acharya, A. Lumley, C. Mebarki, V. Stopa, M. Vausort, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to delineate the role of HIF1α in a SH-SY5Y model of Parkinson’s disease (PD) Background: Parkinson’s disease (PD) is one of…
  • MDS Virtual Congress 2020

    Profile of miRNA expression in CSF of Parkinson’s disease identifies miR-409-3p regulating the apoptosis of dopamine neurons

    X.L Tan, J.Q Tan, F.Y Ming, LL. Lv, H.N Zhang, B.S Tang, W.Q Yan, RR. Bai, X.K Peng, Q.L Xiao, C.Y Wang (Changsha, China)

    Objective: To improve the precise diagnosis of PD at early stage requires more feasible and objective methods. MicroRNA (miRNA) was believed to be a potential…
  • 2019 International Congress

    Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway

    S. Singh, S. Singh (Varanasi, India)

    Objective: This study deals to investigate and explore the anti-apoptotic and molecular mechanisms of CGA in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinsonian mice model. Background: The debilitating…
  • 2019 International Congress

    Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron

    Y. Fan, Z. Xue (Wuhan, China)

    Objective: The study aims to explore the expression profiles of lncRNA of PD patients and its roles to the pathogenesis of PD. Background: The molecular…
  • 2019 International Congress

    Neuroprotective effect of Lemon oil on 6-OHDA-Induced Apoptosis in PC12 Cells through the ROS-NO Pathway

    V. Kumar (Allahabad, India)

    Objective: The objective of current investigation was to decipher e the neuroprotective effect of lemon oil (LO) on PC 12 cell lines by 6-hydroxydopamine (6-OHDA)…
  • 2019 International Congress

    Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

    F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)

    Objective: To evaluate whether type 2 diabetes at baseline is a risk factor for Parkinson's disease. Background: Parkinson’s disease is a chronic disorder in which…
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley